Global Blood Therapeutics (GBT) Competitor Comparison
We are evaluating the key criteria listed to compare Global Blood Therapeutics (GBT) against its competitors in the Biotechnology industry.
Market Capitalization
38 / 368Gross Profits
32 / 278Total Revenue
49 / 300EBITDA
299 / 337Free Cashflow
307 / 352Quick Ratio
165 / 357Earnings per Share
285 / 359Dividend yield
0 / 6Total Cash
60 / 358Performance 3 years
66 / 368Performance 5 years
67 / 368Performance 10 years
63 / 368Linearity 3 years
99 / 368Linearity 5 years
261 / 368Linearity 10 years
139 / 368Total Rank
320 / 368Dividend Rank
142 / 368Valuation Rank
34 / 368Piotroski Rank
162 / 368Muliplier Rank
351 / 368Market Capitalization - GBT ranking 38 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.